Known targets — ChEMBL curated mechanism
ADORA1ADORA2AADORA2BADORA3PDE3APDE3BPDE4APDE4BPDE4CPDE4D
The experimentally established mechanism targets of Glycine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BBOX1 | O75936 | 7/20 | 0.41 |
| ▸ | FFAR3 | O14843 | 2/20 | 0.39 |
| ▸ | HDAC3 | O15379 | 2/20 | 0.39 |
| ▸ | HDAC1 | Q13547 | 2/20 | 0.39 |
| ▸ | HDAC2 | Q92769 | 2/20 | 0.39 |
| ▸ | HDAC8 | Q9BY41 | 2/20 | 0.39 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.36 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.36 |
| ▸ | CA1 | P00915 | 1/20 | 0.34 |
| ▸ | CPT2 | P23786 | 1/20 | 0.33 |
| ▸ | CPT1A | P50416 | 1/20 | 0.33 |
| ▸ | SLC22A16 | Q86VW1 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Acetic Acid SCHEMBL6039286 | 0.86 | CA1 (0.40) | BBOX1FFAR3HDAC3HDAC1HDAC2 | |
| L-Lactic Acid SCHEMBL27743481 | 0.78 | TSHR (0.37) | BBOX1FFAR3HDAC3HDAC1HDAC2 | |
| Tetramethylammonium Ion SCHEMBL9388139 | 0.77 | CPT2 (0.42) | BBOX1FFAR3HDAC3HDAC1HDAC2 | |
| SCHEMBL352085 | 0.77 | — | — | |
| Citric Acid SCHEMBL27511805 | 0.77 | CA4 (0.55) | BBOX1FFAR3HDAC3HDAC1HDAC2 | |
| Glycine SCHEMBL22529120 | 0.77 | DNM1 (0.41) | — | |
| Glycine SCHEMBL28653969 | 0.76 | DNM1 (0.46) | BBOX1FFAR3HDAC3HDAC1HDAC2 | |
| Tetramethylammonium Ion SCHEMBL28584696 | 0.75 | CPT2 (0.41) | BBOX1FFAR3HDAC3HDAC1HDAC2 | |
| Hydrochloric Acid SCHEMBL4850830 | 0.74 | — | — | |
| SCHEMBL1248453 | 0.73 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 558 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4366690-B1 | POLYOL ESTER MIXTURE FOR USE AS VASELINE SUBSTITUTE | BASF SE (DE) | 2025-06-25 | — | — | EP | disclosed |
| US-20240390393-A1 | BOTANICAL EXTRACTS AND COMPOUNDS FROM SCHINUS PLANTS AND METHODS OF USE | EMORY UNIVERSITY (US) | 2024-11-28 | — | — | US | disclosed |
| US-20240325268-A1 | POLYOL ESTER MIXTURE FOR USE AS VASELINE SUBSTITUTE | BASF SE (DE) | 2024-10-03 | — | — | US | disclosed |
| US-20240307413-A1 | BOTANICAL EXTRACTS AND COMPOUNDS FROM SCHINUS PLANTS AND METHODS OF USE | EMORY UNIVERSITY (US) | 2024-09-19 | — | — | US | disclosed |
| US-12083132-B1 | Botanical extracts and compounds from Schinus plants and methods of use | EMORY UNIVERSITY (US) | 2024-09-10 | — | — | US | disclosed |
| EP-4366690-A1 | POLYOL ESTER MIXTURE FOR USE AS VASELINE SUBSTITUTE | BASF SE (DE) | 2024-05-15 | — | — | EP | disclosed |
| EP-4308286-A1 | ACTIVE SUBSTANCE CAPSULES | Symrise AG (DE) | 2024-01-24 | — | — | EP | disclosed |
| US-20230398057-A1 | AGENT FOR DYEING KERATINUOS MATERIAL, COMPRISING AMINOSILICONE, A CHROMOPHORIC COMPOUND AND AN ADDITION PRODUCT OF C1-C6 ALKYLENE OXIDE(S) TO THE ESTERS OF FATTY ACIDS AND AROMATIC ALCOHOLS | HENKEL AG & CO. KGAA (DE) | 2023-12-14 | — | — | US | disclosed |
| US-11633407-B2 | Botanical extracts and compounds from Schinus plants and methods of use | EMORY UNIVERSITY (US) | 2023-04-25 | — | — | US | disclosed |
| US-20230112887-A1 | Pentagalloyl Glucose Derived from Schinus Plants and Methods of Use | UNIV EMORY (US) | 2023-04-13 | — | — | US | disclosed |
| WO-1997004740-A1 | OXIDATION COLORANTS FOR DYEING KERATINIC FIBERS, CONTAINING A SPECIAL COMBINATION OF DEVELOPER COMPONENTS AND ALKALISATION AGENTS | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) | 1997-02-13 | — | — | WO | disclosed |
| WO-1997005224-A1 | POURABLE NACREOUS LUSTRE CONCENTRATE | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) | 1997-02-13 | — | — | WO | disclosed |
| EP-0737211-A1 | CATIONIC BIOPOLYMERS | HENKEL KGAA (DE) | 1996-10-16 | — | — | EP | disclosed |
| WO-1996016991-A1 | CATIONIC BIOPOLYMERS | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) | 1996-06-06 | — | — | WO | disclosed |
| WO-1995034528-A1 | POLYOLPOLYHYDROXYSTEARATES | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) | 1995-12-21 | — | — | WO | disclosed |
| EP-0519946-A1 | SURFACE-ACTIVE MIXTURES | Henkel Kommanditgesellschaft auf Aktien (DE) | 1992-12-30 | — | — | EP | disclosed |
| WO-1991013960-A1 | SURFACE-ACTIVE MIXTURES | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) | 1991-09-19 | — | — | WO | disclosed |
| WO-1990008531-A2 | SURFACE ACTIVE MIXTURES | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) | 1990-08-09 | — | — | WO | disclosed |
| EP-0371339-A2 | Surfactant mixtures | Henkel Kommanditgesellschaft auf Aktien (DE) | 1990-06-06 | — | — | EP | disclosed |
| EP-0337130-A2 | Hair-treating device | Henkel Kommanditgesellschaft auf Aktien (DE) | 1989-10-18 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240325268-A1 | POLYOL ESTER MIXTURE FOR USE AS VASELINE SUBSTITUTE | FASN, DEGS1, ACSL1 | BBOX1 1870/4885FFAR3 40/4885HDAC3 1534/4885 |
| US-20240390393-A1 | BOTANICAL EXTRACTS AND COMPOUNDS FROM SCHINUS PLANTS AND METHODS OF USE | BROX, C5, SYMPK | BBOX1 109/4885FFAR3 2546/4885HDAC3 1676/4885 |
| US-12083132-B1 | Botanical extracts and compounds from Schinus plants and methods of use | BROX, C5, SYMPK | BBOX1 109/4885FFAR3 2546/4885HDAC3 1676/4885 |
| US-20230398057-A1 | AGENT FOR DYEING KERATINUOS MATERIAL, COMPRISING AMINOSILICONE, A CHROMOPHORIC COMPOUND AND AN ADDITION PRODUCT OF C1-C6 ALKYLENE OXIDE(S) TO THE ESTERS OF FATTY ACIDS AND AROMATIC ALCOHOLS | KRT18, C1S, FAM83E | BBOX1 1398/4885FFAR3 163/4885HDAC3 1962/4885 |
| US-20240307413-A1 | BOTANICAL EXTRACTS AND COMPOUNDS FROM SCHINUS PLANTS AND METHODS OF USE | BROX, C5, SYMPK | BBOX1 109/4885FFAR3 2546/4885HDAC3 1676/4885 |
| US-11633407-B2 | Botanical extracts and compounds from Schinus plants and methods of use | BROX, C5, SYMPK | BBOX1 109/4885FFAR3 2546/4885HDAC3 1676/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.